LC1501a : Lung cancer tissue array with different types of lung cancer and normal lung tissue, (2021 WHO classification), including pathology grade, TNM and clinical stage (AJCC 8th edition), 75 cases/150 cores (core size 1.0mm), replacing LC1501
  • $258.00
  • Unstained
  • H&E
-+
Microarray Panel Lung carcinoma microarray with different types lung cancer and normal lung tissue, containing 39 cases of lung adenocarcinoma, 22 squamous cell carcinoma, 5 small cell carcinoma, 3 atypical carcinoid, 1 each of lung mucoepidermoid carcinoma, plus 5 normal lung tissue, duplicate cores per case
Cores 150
TissueArray.Com Tissue Array LC1501a
Cases 75
Row number 10
Column number 15
Core Diameter (mm) 1
Thickness (µm) 5
Quality Control H&E and IHC confirmed
Tissue Array Type FFPE
Species Human
Applications Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes 1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning. 2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers.
Mouseover and click individual cores to view high resolution images.
Slide Label: TissueArray.Com Tissue Array
123456789101112131415 
A 
B 
C 
D 
E 
F 
G 
H 
I 
JMarked point
Legend:

- Malignant tumor, - Malignant tumor (stage IA3), - Malignant tumor (stage IB), - Malignant tumor (stage IC), - Malignant tumor (stage IIA), - Malignant tumor (stage IIB), - Malignant tumor (stage IIIA), - Malignant tumor (stage IIIB), - Malignant tumor (stage IIIC), - Normal tissue

Specification Sheet (Sortable), tissue IDs are available in exported Excel files.
Pos.
No.
Age
Sex
Organ/Anatomic Site
Pathology diagnosis
TNM
Grade
Stage
Type
Image
A1
1
47
F
Papillary adenocarcinoma
T2aN0M0
1
IB
malignant
A2
2
74
M
Acinar adenocarcinoma
T2bN0M0
1
IIA
malignant
A3
3
72
F
Acinar adenocarcinoma
T3N1M0
1
IIIA
malignant
A4
4
69
M
Lepid adenocarcinoma
T1cN0M0
1
IC
malignant
A5
5
50
F
Acinar adenocarcinoma
T2bN1M0
1
IIB
malignant
A6
6
65
F
Acinar adenocarcinoma
T2aN0M0
1
IB
malignant
A7
7
63
F
Papillary adenocarcinoma
T2aN1M0
2
IIB
malignant
A8
8
63
F
Acinar adenocarcinoma
T4N3M0
2
IIIC
malignant
A9
9
64
M
Acinar adenocarcinoma
T1cN0M0
2
IC
malignant
A10
10
73
M
Acinar adenocarcinoma
T3N0M0
2
IIB
malignant
A11
11
61
F
Acinar adenocarcinoma
T2aN1M0
2
IIB
malignant
A12
12
57
M
Papillary adenocarcinoma
T2aN1M0
2
IIB
malignant
A13
13
66
M
Invasive mucinous adenocarcinoma
T3N0M0
2
IIB
malignant
A14
14
69
M
Acinar adenocarcinoma
T2aN0M0
2
IB
malignant
A15
15
52
M
Adenocarcinoma,enteric type (lung tissue)
T2aN1M0
*
IIB
malignant
B1
16
47
F
Papillary adenocarcinoma
T2aN0M0
1
IB
malignant
B2
17
74
M
Acinar adenocarcinoma
T2bN0M0
1
IIA
malignant
B3
18
72
F
Acinar adenocarcinoma
T3N1M0
1
IIIA
malignant
B4
19
69
M
Lepid adenocarcinoma (lung tissue)
T1cN0M0
*
IC
malignant
B5
20
50
F
Acinar adenocarcinoma
T2bN1M0
1
IIB
malignant
B6
21
65
F
Acinar adenocarcinoma (sparse)
T2aN0M0
1
IB
malignant
B7
22
63
F
Papillary adenocarcinoma
T2aN1M0
2
IIB
malignant
B8
23
63
F
Acinar adenocarcinoma
T4N3M0
2
IIIC
malignant
B9
24
64
M
Acinar adenocarcinoma
T1cN0M0
2
IC
malignant
B10
25
73
M
Acinar adenocarcinoma
T3N0M0
2
IIB
malignant
B11
26
61
F
Acinar adenocarcinoma
T2aN1M0
2
IIB
malignant
B12
27
57
M
Papillary adenocarcinoma
T2aN1M0
2
IIB
malignant
B13
28
66
M
Invasive mucinous adenocarcinoma
T3N0M0
2
IIB
malignant
B14
29
69
M
Acinar adenocarcinoma
T2aN0M0
2
IB
malignant
B15
30
52
M
Adenocarcinoma,enteric type
T2aN1M0
2
IIB
malignant
C1
31
52
F
Acinar adenocarcinoma
T2bN1M0
2
IIB
malignant
C2
32
59
F
Acinar adenocarcinoma
T3N0M0
2
IIB
malignant
C3
33
77
F
Acinar adenocarcinoma
T2bN1M0
2
IIB
malignant
C4
34
73
M
Acinar adenocarcinoma
T2bN0M0
2
IIA
malignant
C5
35
54
M
Acinar adenocarcinoma
T3N0M0
2
IIB
malignant
C6
36
70
M
Acinar adenocarcinoma
T2aN0M0
2
IB
malignant
C7
37
67
M
Acinar adenocarcinoma
T2aN0M0
2
IB
malignant
C8
38
51
M
Adenocarcinoma,enteric type
T2bN2M0
2
IIIA
malignant
C9
39
55
F
Acinar adenocarcinoma
T2aN0M0
2
IB
malignant
C10
40
55
F
Acinar adenocarcinoma
T2bN1M0
2
IIB
malignant
C11
41
56
F
Acinar adenocarcinoma
T2bN3M0
2
IIIB
malignant
C12
42
70
M
Acinar adenocarcinoma
T2aN1M0
2
IIB
malignant
C13
43
71
M
Acinar adenocarcinoma
T2aN0M0
2
IB
malignant
C14
44
69
M
Solid adenocarcinoma
T4N0M0
3
IIIA
malignant
C15
45
57
M
Solid adenocarcinoma
T4N1M0
3
IIIA
malignant
D1
46
52
F
Acinar adenocarcinoma (lung tissue)
T2bN1M0
*
IIB
malignant
D2
47
59
F
Acinar adenocarcinoma
T3N0M0
2
IIB
malignant
D3
48
77
F
Acinar adenocarcinoma
T2bN1M0
2
IIB
malignant
D4
49
73
M
Acinar adenocarcinoma
T2bN0M0
2
IIA
malignant
D5
50
54
M
Acinar adenocarcinoma with necrosis
T3N0M0
2
IIB
malignant
D6
51
70
M
Acinar adenocarcinoma
T2aN0M0
2
IB
malignant
D7
52
67
M
Acinar adenocarcinoma
T2aN0M0
2
IB
malignant
D8
53
51
M
Adenocarcinoma,enteric type
T2bN2M0
2
IIIA
malignant
D9
54
55
F
Acinar adenocarcinoma (sparse)
T2aN0M0
2
IB
malignant
D10
55
55
F
Acinar adenocarcinoma
T2bN1M0
2
IIB
malignant
D11
56
56
F
Acinar adenocarcinoma
T2bN3M0
2
IIIB
malignant
D12
57
70
M
Acinar adenocarcinoma
T2aN1M0
2
IIB
malignant
D13
58
71
M
Acinar adenocarcinoma
T2aN0M0
2
IB
malignant
D14
59
69
M
Solid adenocarcinoma
T4N0M0
3
IIIA
malignant
D15
60
57
M
Solid adenocarcinoma
T4N1M0
3
IIIA
malignant
E1
61
56
M
Acinar adenocarcinoma
T2bN1M0
3
IIB
malignant
E2
62
47
M
Solid adenocarcinoma
T2aN0M0
3
IB
malignant
E3
63
59
M
Acinar adenocarcinoma
T2bN3M0
3
IIIB
malignant
E4
64
55
M
Solid adenocarcinoma
T2aN3M0
3
IIIB
malignant
E5
65
57
M
Solid adenocarcinoma
T2bN0M0
3
IIA
malignant
E6
66
63
M
Papillary adenocarcinoma
T2bN0M0
3
IIA
malignant
E7
67
27
M
Acinar adenocarcinoma
T3N2M0
3
IIIB
malignant
E8
68
69
M
Squamous cell carcinoma,keratinizing
T3N0M0
2
IIB
malignant
E9
69
75
M
Squamous cell carcinoma,keratinizing
T2bN1M0
2
IIB
malignant
E10
70
63
M
Squamous cell carcinoma,keratinizing
T2bN1M0
2
IIB
malignant
E11
71
55
M
Squamous cell carcinoma,nonkeratinizing
T3N0M0
3
IIB
malignant
E12
72
56
M
Squamous cell carcinoma,nonkeratinizing
T3N0M0
3
IIB
malignant
E13
73
54
F
Squamous cell carcinoma,keratinizing
T3N1M0
2
IIIA
malignant
E14
74
55
M
Squamous cell carcinoma,nonkeratinizing
T4N1M0
2
IIIA
malignant
E15
75
75
M
Squamous cell carcinoma,nonkeratinizing
T1cN1M0
2
IIB
malignant
F1
76
56
M
Acinar adenocarcinoma
T2bN1M0
3
IIB
malignant
F2
77
47
M
Solid adenocarcinoma
T2aN0M0
3
IB
malignant
F3
78
59
M
Acinar adenocarcinoma
T2bN3M0
3
IIIB
malignant
F4
79
55
M
Solid adenocarcinoma
T2aN3M0
3
IIIB
malignant
F5
80
57
M
Solid adenocarcinoma
T2bN0M0
3
IIA
malignant
F6
81
63
M
Papillary adenocarcinoma
T2bN0M0
3
IIA
malignant
F7
82
27
M
Acinar adenocarcinoma
T3N2M0
3
IIIB
malignant
F8
83
69
M
Squamous cell carcinoma,keratinizing
T3N0M0
2
IIB
malignant
F9
84
75
M
Squamous cell carcinoma,keratinizing
T2bN1M0
2
IIB
malignant
F10
85
63
M
Squamous cell carcinoma,keratinizing
T2bN1M0
2
IIB
malignant
F11
86
55
M
Squamous cell carcinoma,nonkeratinizing
T3N0M0
3
IIB
malignant
F12
87
56
M
Squamous cell carcinoma,nonkeratinizing
T3N0M0
3
IIB
malignant
F13
88
54
F
Squamous cell carcinoma,keratinizing
T3N1M0
2
IIIA
malignant
F14
89
55
M
Squamous cell carcinoma,nonkeratinizing
T4N1M0
2
IIIA
malignant
F15
90
75
M
Squamous cell carcinoma,nonkeratinizing
T1cN1M0
2
IIB
malignant
G1
91
65
M
Basoloid squamous cell carcinoma
T2bN0M0
3
IIA
malignant
G2
92
57
M
Squamous cell carcinoma,nonkeratinizing
T3N3M0
3
IIIC
malignant
G3
93
63
M
Squamous cell carcinoma,keratinizing
T3N0M0
2
IIB
malignant
G4
94
57
M
Squamous cell carcinoma,keratinizing
T3N0M0
2
IIB
malignant
G5
95
64
F
Squamous cell carcinoma,keratinizing
T3N1M0
1
IIIA
malignant
G6
96
64
M
Squamous cell carcinoma,keratinizing
T2aN0M0
1
IB
malignant
G7
97
63
M
Squamous cell carcinoma,keratinizing
T2aN0M0
1
IB
malignant
G8
98
69
M
Squamous cell carcinoma,nonkeratinizing
T4N0M0
3
IIIA
malignant
G9
99
51
F
Squamous cell carcinoma,nonkeratinizing
T4N3M0
3
IIIC
malignant
G10
100
57
M
Squamous cell carcinoma,nonkeratinizing
T2bN1M0
3
IIB
malignant
G11
101
48
M
Squamous cell carcinoma,nonkeratinizing
T2bN0M0
3
IIA
malignant
G12
102
68
M
Squamous cell carcinoma,keratinizing
T2aN0M0
3
IB
malignant
G13
103
70
M
Squamous cell carcinoma,nonkeratinizing
T3N0M0
3
IIB
malignant
G14
104
61
M
Squamous cell carcinoma,nonkeratinizing
T3N0M0
3
IIB
malignant
G15
105
67
M
Small cell carcinoma
T2aN0M0
-
IB
malignant
H1
106
65
M
Basoloid squamous cell carcinoma
T2bN0M0
2
IIA
malignant
H2
107
57
M
Squamous cell carcinoma,nonkeratinizing
T3N3M0
2
IIIC
malignant
H3
108
63
M
Squamous cell carcinoma,keratinizing
T3N0M0
2
IIB
malignant
H4
109
57
M
Squamous cell carcinoma,keratinizing
T3N0M0
2
IIB
malignant
H5
110
64
F
Squamous cell carcinoma,keratinizing (necrosis)
T3N1M0
*
IIIA
malignant
H6
111
64
M
Squamous cell carcinoma,keratinizing
T2aN0M0
2
IB
malignant
H7
112
63
M
Squamous cell carcinoma,keratinizing
T2aN0M0
2
IB
malignant
H8
113
69
M
Squamous cell carcinoma,nonkeratinizing (fibrous adipose tissue)
T4N0M0
*
IIIA
malignant
H9
114
51
F
Squamous cell carcinoma,nonkeratinizing
T4N3M0
3
IIIC
malignant
H10
115
57
M
Squamous cell carcinoma,nonkeratinizing
T2bN1M0
3
IIB
malignant
H11
116
48
M
Squamous cell carcinoma,nonkeratinizing
T2bN0M0
3
IIA
malignant
H12
117
68
M
Squamous cell carcinoma,keratinizing
T2aN0M0
3
IB
malignant
H13
118
70
M
Squamous cell carcinoma,nonkeratinizing
T3N0M0
3
IIB
malignant
H14
119
61
M
Squamous cell carcinoma,nonkeratinizing
T3N0M0
3
IIB
malignant
H15
120
67
M
Small cell carcinoma
T2aN0M0
3
IB
malignant
I1
121
58
M
Small cell carcinoma
T2aN0M0
-
IB
malignant
I2
122
53
M
Small cell carcinoma
T4N1M0
-
IIIA
malignant
I3
123
62
M
Small cell carcinoma
T2bN1M0
-
IIB
malignant
I4
124
47
M
Small cell carcinoma
T1cN0M0
-
IA3
malignant
I5
125
54
M
Atypical carcinoid
T2aN0M0
-
IB
malignant
I6
126
65
M
Atypical carcinoid
T2bN0M0
-
IIA
malignant
I7
127
35
M
Atypical carcinoid
T2aN1M0
-
IIB
malignant
I8
128
78
M
Mucoepidermoid carcinoma
T3N1M0
-
IIIA
malignant
I9
129
59
M
Colloid adenocarcinoma
T2bN1M0
-
IIB
malignant
I10
130
55
F
Solid adenocarcinoma
T2bN0M0
-
IIA
malignant
I11
131
45
F
Lung tissue
-
-
-
normal
I12
132
40
F
Lung tissue
-
-
-
normal
I13
133
21
F
Lung tissue
-
-
-
normal
I14
134
48
M
Lung tissue
-
-
-
normal
I15
135
24
M
Lung tissue
-
-
-
normal
J1
136
58
M
Small cell carcinoma
T2aN0M0
-
IB
malignant
J2
137
53
M
Small cell carcinoma
T4N1M0
-
IIIA
malignant
J3
138
62
M
Small cell carcinoma
T2bN1M0
-
IIB
malignant
J4
139
47
M
Small cell carcinoma
T1cN0M0
-
IA3
malignant
J5
140
54
M
Atypical carcinoid
T2aN0M0
-
IB
malignant
J6
141
65
M
Atypical carcinoid
T2bN0M0
-
IIA
malignant
J7
142
35
M
Atypical carcinoid
T2aN1M0
-
IIB
malignant
J8
143
78
M
Mucoepidermoid carcinoma
T3N1M0
-
IIIA
malignant
J9
144
59
M
Colloid adenocarcinoma
T2bN1M0
-
IIB
malignant
J10
145
55
F
Solid adenocarcinoma
T2bN0M0
-
IIA
malignant
J11
146
45
F
Lung tissue
-
-
-
normal
J12
147
40
F
Lung tissue
-
-
-
normal
J13
148
21
F
Lung tissue
-
-
-
normal
J14
149
48
M
Lung tissue
-
-
-
normal
J15
150
24
M
Lung tissue
-
-
-
normal
-
0
42
M
Adrenal gland
Pheochromocytoma (tissue marker)
-
Malignant
Find overlapping cases with this tissue array:
 

Write a review

Please login or register to review
 
  • Product Code: LC1501a
  • Availability: In Stock

Tags: Duplicate cores per case, Stage (TNM), With normal control ()